skinny.

Latest / Eyewire News: The Podcast

FDA Issues CRL to Regeneron for Eylea HD Extended Dosing

The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.